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Abstract
Specific cleavage of RNAs is critical for in vitro manipulation of RNA and for in vivo gene 
silencing. Here we engineer artificial site-specific RNA endonucleases (ASREs) to function 
analogously to DNA restriction enzymes. We combine a general RNA cleavage domain with a 
series of Pumilio/FBF (PUF) domains that specifically recognize different 8-nt RNA sequences. 
The resulting ASREs specifically recognize RNA substrates and efficiently cleave near their 
binding sites. ASREs can be devised to recognize and cleave various RNA target sequences, 
providing a useful tool to manipulate RNAs in vitro. In addition, we generate designer ASREs to 
specifically silence an endogenous gene in E. coli, as well as a mitochondrial-encoded gene in 
human cells, suggesting that ASREs can serve as a gene silencing tool with designed specificity.
Introduction
The discovery of type II DNA restriction enzymes nearly 40 years ago marked the birth of 
the recombinant DNA era. However, despite extensive investigations, an equivalent enzyme 
that cleaves RNA in a sequence-specific manner has not been found in nature. The known 
RNA endonucleases either cleave their targets through recognition of specific structures 
(e.g., RNase III family or RNase H) 1,2, or have limited sequence specificity (e.g., RNase A 
or RNase T1). The molecular machineries that Mother Nature has evolved for sequence-
specific RNA cleavage (e.g., RNAi machinery) involve multi-component complexes that 
require a guide RNA for target recognition and a protein-RNA assembly for activity, 
limiting their application in probing structured RNA or manipulating recombinant RNA in 
vitro. As a gene-silencing method, RNAi is also restricted to target mRNA in the organisms 
with a reliable RNAi pathway, thus can not cleave RNA in other cellular compartments 
(such as mitochondrial RNA) or be used in some parasitic protozoa (such as Leishmania and 
Plasmodium) 3.
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Previously the hammerhead ribozymes or DNAzymes and PNAzyme have been engineered 
to achieve site-specific RNA cleavage 4,5. However, these nucleic acid enzymes generally 
have low turnover rates compared to protein enzymes, possibly due to tight binding to their 
substrates. The application of such nucleic acid enzymes is further compromised by the high 
production cost and low stability of RNA, as well as by the lack of control over folding of 
single-stranded RNA or DNA. Therefore it is highly desirable to create RNA “restriction 
enzymes” as simple proteins that can be produced with general recombinant protein 
technologies and expressed in various cells with different gene expression systems.
To create a “restriction enzyme” for RNA, we have engineered a new class of 
endoribonucleases, called artificial site-specific RNA endonucleases (ASREs), that can 
specifically recognize an 8-nt RNA sequence and make a single cleavage in the target. We 
further determined the cleavage sites and the kinetics parameters of these new enzymes. Our 
data indicate that these endoribonucleases are capable of efficiently and specifically cleaving 
diverse RNA targets not only in vitro, but also in cultured cells. To our knowledge this work 
marks the first reported restriction enzyme for RNA, which may have important implications 
in the development of new RNA-engineering technologies and gene-silencing methods.
Results
Design of ASREs
To create a “restriction enzyme” for RNA, we adopted a modular design by combining a 
target recognition domain and a catalytic domain. For the target recognition domain, we 
chose the unique RNA binding domain (PUF domain) of human PUM1 that contains eight 
repeats to recognize eight consecutive RNA bases 6,7 (Fig. 1a). Two amino acids in each 
repeat specifically interact with the Watson-Crick edge of each corresponding base. Thus, 
by modifying these amino acids in each repeat, a PUF domain can be reprogrammed to bind 
any 8-nt RNAs 6–9. For the RNA cleavage module, we used the PIN domain (PilT N-
terminus) of SMG6, which is a non-specific endonuclease domain with well-defined 
molecular architecture and requires only a divalent cation for its activity 10–12 (Fig. 1a). We 
connected the two domains with a heptapeptide linker (VDTGNGS) designed based on the 
amino acid propensity of natural linkers in multi-domain proteins 13. The detailed 
procedures for ASRE construction were shown in Supplemental Methods and 
Supplementary Table S1.
We first constructed an ASRE in the PUF-PIN configuration from N- to C-terminus using a 
modified PUF(6-2/7-2) that specifically binds UugAUAUA (7u6g, see Methods and 
Supplementary Table S2) 7. The recombinant ASREs were purified (Supplementary Fig. S1) 
and incubated with a 191-nt RNA substrate containing its cognate 8-nt target. We observed a 
rapid cleavage of the substrate into two fragments with expected sizes. In contrast, the 
control ASRE with an inactive PIN domain (D1353A mutation in PIN active site 11) had no 
detectable activity (Fig. 1b), suggesting that the cleavage was indeed catalyzed by the PIN 
domain. The RNA cleavage was nearly complete within two hours (Fig. 1c). An inverted 
ASRE with PIN-PUF configuration showed non-specific RNA cleavage (Fig 1b), we thus 
chose the PUF-PIN orientation in our subsequent studies.
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Sequence specificity and ion requirement of ASREs
To test for specificity, we created an ASRE containing the wild type PUF that recognizes the 
nanos response element (NRE: UGUAUAUA) that differs from the PUF(6-2/7-2) target by 
two nucleotides 7. The ASRE(wt) cleaved only the substrate containing the NRE sequence 
(Fig. 1d, lane 3) but not the closely related 7u6g sequence (lane 2). Conversely, the 
ASRE(6-2/7-2) specifically cleaved its cognate target but not the NRE containing substrate 
(Fig. 1d). In addition, the ASRE(6-2/7-2) failed to cleave other closely related RNAs that 
vary by 3 to 6 nucleotides from its substrate (Supplementary Fig. S2 and Supplementary 
Table S2), suggesting that the ASRE activity is highly sequence-specific.
Consistent with the metal ion selectivity of the PIN domain 11, we detected optimal activity 
of ASRE in the presence of Mn2+ and suboptimal activity in the presence of Mg2+ (Fig. 1e). 
We made a new observation that the PIN domain may use Co2+ as a low-activity substitute, 
as weak ASRE activity was observed in the presence of Co2+ (Fig. 1e, lane 5). Although 
ssDNA can inhibit the non-specific nuclease activity of PIN 11, it did not affect the specific 
cleavage by ARSE (Supplementary Fig. S3). This is consistent with the fact that PUF 
domains do not bind ssDNA 6. We further measured the initial cleavage rates 
(Supplementary Fig. 4a) to estimate the kinetic parameters of four related ASREs 
(Supplementary Table S3). The ASRE-catalyzed RNA cleavage roughly followed a 
Michaelis-Menten-like kinetics in our assay conditions (Supplementary Fig. S4), and the 
cleavage was fairly efficient with kcat/KM around the 107 M−1min−1 range and KM around 
the 1–3µM range. This is an approximate estimation as the ASRE proteins were assumed 
100% active in the calculations and the initial rates were measured in a 5-minute reaction 
due to our detection limit. In the future, a more detailed enzyme kinetics study will facilitate 
the optimization of ASREs.
Determining cleavage site of ASREs
Our data indicated that ASRE-mediated RNA cleavage occurs near the cognate binding site, 
generating two products whose combined length roughly equals to the length of input RNA 
as judged by urea-PAGE gel. To determine the exact site of ASRE cleavage, we cloned and 
sequenced both the 5′ and 3′ digestion products from the same reaction using 5′- and 3′-
RACE (Supplementary Fig. S5a and S5b). Due to a polyadenylated fragment added during 
cloning processes, the resulting products do not form a band with a fixed size 
(Supplementary Fig. S5c). We sequenced 41 clones in total to determine the 5′ and 3′ sites, 
and analyzed cleavage sites supported by multiple clones. The fact that digested products 
can be cloned with RACE indicated that RNA cleavage catalyzed by ASRE generates a 5′ 
fragment with 3′ hydroxyl group.
Two cleavage sites (site 1 and 2) were identified by 5′ and 3′ RACE (Fig. 1f). The cleavage 
products of the major site were matched to the same position using both 5′ and 3′ RACE 
(Supplementary Fig. S5c), suggesting the ASRE makes a single cut in each RNA molecule. 
The major site was located 4 bases downstream of the PUF binding site and accounted for 
~60% of sequenced clones, whereas the minor site was in the third position of the 8-nt PUF 
binding site (Fig. 1f). Since PUF binds RNA in an anti-parallel fashion with the first repeat 
at the N-terminus recognizing the 8th RNA position, such a cleavage pattern indicated that 
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ASREs probably forms a “fold-back” structure with the RNA substrate being bound by the 
one arm (PUF domain) and the catalytic PIN domain folding back to cleave the 
phosphodiester backbone at downstream sites (Fig. 1g). We also observed minor cleavage 
sites near the PUF binding sequence that were mapped by single clones; such sites could be 
accounted for by experimental artifact of RNA amplification with RACE, by incomplete 
ASRE digestion, or by flexibility of the ASRE-RNA complex. In addition, the fact that RNA 
can also form secondary and tertiary structure in solution adds complexity to this model. The 
exact mechanism as to how ASREs select the cleavage sites will require determining the 3D 
structure of an ASRE-RNA complex.
Length and structure of linker affects ASRE activity
We further examined how different linkers affected the activities of an ASRE. A suitable 
linker is key to high catalytic activity, however, designing the linker is a major challenge 
due to lack of prior knowledge of domain flexibility imparted by inter-domain structures. A 
linker longer than what is necessary to connect two domains may be too flexible and thus 
could act as an energetic, structural, or activity-interfering nuisance 14. On the other hand, a 
short linker may generate a structural barrier that prevents simultaneous contact of the two 
domains with the RNA substrate. A database of known linkers revealed that both short (< 6 
amino acids) and long linkers (>14 amino acids) are very rare in nature and a typical linker 
is 6–12 amino acids in length mostly in helical structures 13. To optimize the ASRE linker 
length, we designed tripeptide (VDT; 7.3Å), heptapeptide (VDTGNGS; 12Å) and 
dodecapeptide (VDRRMARDGLVH; 20.5Å) linkers and inserted them between 
PUF(6-2/7-2) and wild type PIN (Fig. 2a). These peptides have mixed helical propensity and 
should provide limited flexibility to prevent non-native interactions between domains (http://
www.ibi.vu.nl/programs/linkerdbwww/).
We found that the purified ASRE with tri-peptide linker had very low activity compared to 
the other two enzymes (Fig. 2a, lane 2). The enzymes had considerably higher activities with 
linker lengths of 7 aa or 12 aa. However, non-specific cleavage products became apparent at 
longer incubation time with the 12-aa linker (Fig. 2a, lane 5), probably due to excessive 
flexibility that allowed the PIN endonuclease domain to access and cleave non-cognate sites. 
Furthermore, the secondary structure of peptide linkers may also affect the efficiency of 
ASRE mediated RNA cleavage. When assuming that the inter-domain linker in ASRE 
would adopt a structure similar to that in their native contexts, we found linkers with α-
helical or helix-coil-helix structures produced more active ASREs, whereas linkers with 310 
helix structures reduced the activity (Fig. 2b).
Silencing gene expression with ASRE in living cells
A potential application of this new class of enzymes is to customize ASREs that specifically 
silence gene expression, which is especially useful in places where the RNAi machinery is 
not present. As a proof of concept, we designed an ASRE to target the lacZ transcript in E. 
coli. We engineered the ASRE(LacZ) by changing PUF repeats 2, 3, and 6 to specifically 
recognize UGgAUgaA sequence in positions 1232–1239 and 1520–1527 of the lacZ. We 
used BL21(DE3) cells where expression of the ASRE and lacZ can be induced by IPTG. 
The controls include the non-specific ASRE(87621) that targets a different sequence and the 
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mutated ASRE(LacZ) containing a D1353A mutation in the PIN active site. We found that 
the bacteria expressing ASRE(LacZ) had significantly decreased β-galactosidase activity 
compared to empty vector controls or non-specific ASRE controls (Fig. 3a). Consistent with 
in vitro results (Fig. 1b), the ASRE(LacZ) with an inactive PIN domain have essentially no 
effect, suggesting that the decrease is due to mRNA cleavage by ASRE(LacZ) rather than a 
translational inhibition. We further measured the steady-state RNA level of the lacZ 
transcript, and found that expression of ASRE(LacZ) significantly decreased lacZ RNA 
compared to the empty vector or control ASRE (Fig. 3b). ASRE(LacZ) with a D1353A 
mutation in the PIN domain had some residual activity and decreased the LacZ RNA level 
by half, consistent with reports that this mutation cannot completely eliminate PIN activity 
in vivo 10,11. The β-galactosidase protein levels were also decreased by ASRE(LacZ) as 
judged by western blots (Supplementary Fig. S6). This effect is not due to differential 
expression of ASREs as the ASRE levels in all clones were roughly equal (Supplementary 
Fig. S6, bottom panel). As a control, expression of the PIN domain alone caused non-
specific degradation of total RNA (Supplementary Fig. S7), generating a smear of short 
RNA fragments in the Urea-PAGE gel. This is consistent with previous reports that the PIN 
domain functions as a non-specific RNA endonuclease 10,11. Because expression of the PIN 
domain is toxic to E. coli cells, a complete degradation of total RNA was not observed 
(Supplementary Fig. S7).
The off-target effects of ASRE(LacZ) were further determined by measuring the RNA levels 
of four genes with qRT-PCR in cells transformed with ASRE(LacZ) or empty vector (Fig. 
3c). The first two genes - eutE (acc #: ECBD_1235) and yjcS (ECBD_3947) - contain a 
single copy of the target sequence, whereas the fstX gene (ECBD_0279) contains a site with 
a single mis-match from the target (Fig. 3c) and the adhP (ECBD_2161) gene does not 
harbour a similar site. A significant decrease in RNA level was observed only for lacZ but 
not for eutE or yjcS (both containing a single target site) or other RNAs (Fig. 3c). A possible 
reason may be that the LacZ RNA is induced together with ASRE expression whereas other 
RNAs were occupied and protected by ribosomes before ASRE expression (see Discussion). 
We developed a web-based application to help select the target sites of ASREs with minimal 
off-target effect (http://www.unc.edu/usr-bin/ytsai/Puf.cgi). This program scans for all the 8-
nt sequences in the target RNA and control RNAs for enriched 8-nt sequences. Multiple 
sequences or a long sequence (e.g. a small genome) can be used as controls. The program 
reports the 8-nt found only in the target sequence but not in the controls (the optimal 8-nt 
sites were ranked in the order of copy numbers). The possible secondary structure around 
the 8-nt binding site was also reported to ensure that there is no stably paired structure to 
prevent PUF binding (the maximal number of basepairs allowed is set as three). We 
empirically require at least three bases in the 8-nt binding sites to be unpaired.
Gene silencing by ASRE in mitochondria
To expand the application of ASREs as a gene-silencing tool, we generated a new ASRE to 
target mitochondria-encoded genes. Human mitochondria contain a circular DNA genome 
that encodes 13 proteins in the respiratory chain and mitochondrial tRNAs and rRNAs (Fig. 
4a). Mutations in mitochondrial DNA are closely associated with various human diseases 
and aging 15,16, however, it is difficult to study the functions of mitochondria-encoded genes 
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because there are limited tools available to manipulate their expression. We engineered 
mitochondrial ASRE (mitoASRE) by including an N-terminal targeting peptide from 
ornithine transcarbamylase (OTC) to facilitate mitochondrial protein import 17 (Fig. 4a). 
Control ASREs with inactive PIN or lacking mitochondrial targeting peptides were also 
generated (Fig. 4b). To minimize non-specific cleavage, we targeted a unique 8-nt (position 
13,354 of NC_012920) in the mitochondrial genome within the NADH dehydrogenase 
subunit 5 (mtND5). Upon transient transfection into cultured cells, the mitoASREs were 
imported into mitochondria as judged by immunofluorescence staining (Fig. 4c and 
Supplementary Fig. S8), whereas the control ASRE(ND5) was mainly found in the 
cytoplasm. We observed a small decrease (20–30%) of mtND5 mRNA in mitoASRE(ND5) 
transfected cells using real time RT-PCR, likely due to low transfection efficiency and/or 
inadequate protein production/import.
For a more robust expression, we used Flp-In T-REx system to generate stable cell lines that 
produce mitoASREs upon tetracycline induction. We observed an approximately 70% 
decrease of mtND5 RNA in cells expressing mitoASRE(ND5) compared to uninduced cells 
(Fig. 4d). Interestingly, cells expressing inactive mitoASRE increased the mtND5 RNA 
level compared to the uninduced cells. This unexpected result was reproduced in multiple 
inductions, possibly because the binding of inactive mitoASRE(ND5) stabilized mtND5 
RNA. The mitoASRE(ND5), but not the inactive control, reduced ND5 protein level as 
judged by western blot (Fig. 4e). As controls, the levels of two additional mitochondrial 
proteins (COX1 and CytB) were found unchanged (Fig. 4e).
We further measured the biosynthesis of all mitochondria-encoded proteins using a 
translation assay with S35> labeled methionine and emitine, and found that the biosynthesis 
of ND5, but not other mitochondria-encoded proteins, were significantly decreased by 
mitoASRE(ND5) (Supplementary Fig. S9). As a control, the expression of mutated 
mitoASRE(ND5) did not affect mitochondrial protein synthesis, suggesting that the reduced 
level of ND5 translation is due to specific mRNA degradation. In addition, the off-target 
effects of mitoASRE(ND5) were evaluated by measuring the change in RNA levels for all 
mitochondrial protein-coding genes and rRNAs after tetracycline induction. We found that 
only the ND5 RNA showed a significant decrease (by 72%), whereas the levels of other 
RNAs did not change or slightly increased (Supplementary Fig. S10a).
The cells expressing mitoASRE(ND5) showed a slow growth during the first 2–3 days of 
induction (Supplementary Fig. S10b), however this phenotype is transient and the cells 
eventually recovered to normal growth. Since mtND5 is a subunit of the mitochondrial 
respiratory complex I, we measured complex I activities after the induction of wildtype or 
mutated mitoASRE(ND5) (Fig. 4f). mitoASRE(ND5), but not the inactive mutant, caused a 
modest but reproducible decrease in total complex I activity (Fig. 4f, p=0.0014), consistent 
with previous clinical findings 18,19. The detailed mechanism of how mtDN5 silencing can 
affect cell metabolism is interesting but beyond the scope of this study.
Choudhury et al. Page 6














In this study, we engineered a series of RNA “restriction enzymes” using rational protein 
design from different functional modules. Similar designs have been applied to artificial 
DNA enzymes (aka zinc-finger nucleases, ZFNs), where a zinc finger DNA-binding domain 
and a DNA-cleavage domain are combined20 to target unique sequences within complex 
genomes 21. However, restriction enzymes targeting RNA have not been discovered in 
nature and the creation of artificial enzymes resembling ZFNs has been proven difficult, 
primarily due to limited understandings of a recognition code for RNA-protein 
interactions 22. We have taken advantage of the specific RNA binding “code” of the PUF 
domain and the endonuclease activity of the PIN domain. Generating this novel class of 
enzymes enables efficient and specific cleavage of diverse RNA targets both in vitro and in 
vivo.
Key considerations for the successful generation of ASREs include selections of a sequence-
specific RNA binding domain, a suitable endonuclease domain, an optimal linker, and a 
correct orientation of these elements. Our data suggest that the unique RNA recognition 
mode of the PUF domain renders ASREs the ability to specifically recognize a diverse panel 
of RNA targets without detectable cross activity between non-cognate ASRE/RNA pairs. 
We also demonstrate that the PIN domain of human SMG6 cleaves RNAs at specific sites 
only when fused to the C-terminus of the PUF domain, but not in a reverse orientation (Fig. 
1b). One possible explanation is that the PIN in PUF-PIN orientation can “fold back” so that 
the active site faces the RNA bound by the PUF domain to specifically cleave the substrate 
(Supplementary Fig. S11a), whereas in PIN-PUF orientation, the PIN active site faces away 
from PUF to cleave any nearby RNA (Supplementary Fig. S11b). Alternatively, the bridge 
region joined by the linker and the C-terminal residues of PIN could be very flexible, 
allowing non-specific RNA sequences to become accessible to the PIN active site when 
ASRE is constructed in a PIN-PUF orientation (Supplementary Fig. S11c). We further found 
that medium-sized linkers (7–12 amino acids) rich in slightly polar hydrophilic amino acids 
are best suited for the design. When assuming the inter-domain linker in ASRE to adopt a 
structure similar to that in their native contexts, we found that linkers with α-helical or 
helix-coil-helix structures produced the most active ASREs, whereas linkers with 310 helix 
structures reduced the activity of ASREs (Fig. 2). Furthermore, the linker length also affects 
the specificity of the enzyme: non-specific cleavage became apparent with linkers 
approaching ~20Å in length (Fig. 2), probably due to excess flexibility that allowed the PIN 
endonuclease domain to recognize and cleave any RNA. Alternatively, longer linkers might 
directly affect binding of PUF to the RNA (e.g. by steric hindrance at RNA-PUF binding 
surfaces), leading to non-specific binding and cleavage by ASRE. Thus the independent 
domain movement should be considered an important parameter in controlling non-specific 
cleavage.
Several lines of evidence confirm that RNA cleavage by ASREs is indeed catalyzed by the 
PIN domain of SMG6: (1) ASRE has the same cation preference as that of PIN (Fig. 1e), 
both requiring Mn2+ for maximum activity 11; (2) A mutation in the active site of the PIN 
domain abolished ASRE activity; (3) Non-specific RNA cleavage was observed when the 
PIN domain had too much flexibility to recognize any RNA (either with a long linker or a 
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reverse PIN-PUF orientation), consistent with non-specific activities of the PIN domain 11. 
The specificity of ASRE is determined by an 8-nt recognition site, which is similar to the 
length of the seed match for RNAi 23. To minimize off-target effects during in vivo 
application, one might preferably select PUFs to recognize an 8-nt sequence present in 
multiple copies in the target RNA.
Many factors might influence the ASRE efficiency. RNA structures may affect the specific 
recognition between PUF and target RNA or change the accessibility of the PIN domain to 
the cleavage site, suggesting that when requiring efficient cleavage we should select target 
sites in regions that lack a stable structure. For in vivo applications, the expression window 
of ASRE may also affect its efficiency. For example, the expression of both T7-driven 
ASRE and chromosomal lacZ in E. coli were induced simultaneously with IPTG. Since the 
T7 RNA polymerase is almost 8 times faster than the bacterial RNA polymerase 24, ASRE 
was presumably synthesized faster than lacZ, providing a time window for the ASRE to 
cleave lacZ mRNA. The observation that ASRE(lacZ) could specifically silence lacZ 
expression suggested that the ASRE can recognize its target with sufficiently high efficiency 
and affinity to overcome the protective effect of ribosomes. As an added benefit, the co-
transcriptional binding of mRNA by ribosomes may limit low affinity off-target effects of 
ASREs, as only the specific ASRE with high binding affinity could compete efficiently with 
ribosomes. One may also express ASRE from constitutive promoters to ensure that the 
ASRE is present when the target RNA is being synthesized.
As the first generation of ASRE, there are various ways to optimize its activity and expand 
its application. For example, it may be possible to create ASREs that recognize a target of 
different length (other than 8-nt). ASREs capable of recognizing longer sites may minimize 
off-target effects, whereas a shorter targeting site will be helpful for probing RNA 
structures. In addition, the catalytic activity of ASRE may also be improved by using RNA 
endonuclease domains other than PIN, or by optimizing the PIN domain active site. Finally, 
the relative positions of the cleavage sites are probably affected by the conformation of the 
linker region, thus testing peptide linkers with different sequences and structures will likely 
reduce the “star activity” of ASREs so that the cleavage occurs at a single, predictable site. 
The modular design combining an RNA recognition domain with a functional domain has 
been applied in engineering artificial factors to modulate splicing 25 or to visualize RNAs in 
live cells 26, and similar configurations may be applied to devise new proteins for specific 
manipulations of RNA.
Methods
Construction and expression of ASREs
The PUF domain of human Pum1 (residue 828–1176) and the PIN domain of human Smg6 
(residue 1238–1421) were amplified with PCR and joined by sequences encoding different 
peptide linkers designed according to amino acid propensity of known protein linkers (http://
www.ibi.vu.nl/programs/linkerdbwww). The resulting fusion proteins were cloned in 
expression vector pT7HTb or pET43.1b and purified for analyses of their activities. See 
supplemental methods for more details.
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The ASREs were named according to the identity of their PUF domains, since most ASRE 
had the same PIN domain. Each PUF domain recognizes its 8-nt target sequence in an anti-
parallel fashion, with the first repeat recognizing the 8th base and so on.
WT PUF repeat : C terminus- 8 7 6 5 4 3 2 1 – N terminus
RNA target (5’ to 3’ ends): 5’-U G U A U A U A-3’
We named the targets of a modified PUF in a reverse order (from C to N terminus) with the 
number of mutated PUF repeat and the base recognized by the corresponding repeat. For 
example, RNA target 7u6g represents UugAUAUA sequence, with the mutated base shown 
in lower case. The PUF domains were named by the mutated repeats and the number of 
mutated amino acid in each in each repeat is marked. For example ASRE(6-2/7-2) has two 
mutated amino acids in each of 6th and 7th repeat, causing it to recognize the 7u6g RNA. See 
supplementary table S2 for more examples.
Determination of the RNA cleavage site
To determine the cleavage sites of ASREs, we extracted the 5′ and 3′ digestion products 
from denaturing urea- PAGE gels, and used RACE to map both ends of the cleavage 
products. To map the 3′ end of the 5′ fragment, we used polyA polymerase to add a 10–30 nt 
poly-A tail at the end of 5′ fragment, and reverse transcribed the resulting RNA with a poly-
T containing primer. The resulting cDNA was amplified by nested PCR, cloned in pcDNA3, 
and sequenced (Supplementary Fig. S5a, left panel). To map the 5′ end of the 3′ cleavage 
product (Supplementary Fig. S5a, right panel), the gel extracted RNA was first reverse 
transcribed with a specific primer. The resulting cDNA was purified and elongated with 
terminal transferase in the presence of dATP. Second strand synthesis was carried out using 
a poly-T-containing primer and Klenow fragment. The resulting product was PCR 
amplified, cloned and sequenced.
Gene silencing by ASRE in bacterial cells
E. coli BL21(DE3) was transformed with either empty vector pET43.1b, or the vector 
encoding ASRE(LacZ) or a control ASREs not targeting lacZ mRNA. Multiple colonies 
were selected in each sample to circumvent clonal variation. Protein expression of each 
clone was induced with 0.3 mM IPTG for 6h at 37°C. To measure β-galactosidase activity, 
cells were lysed with two rounds of sonication in cold buffer and the standard β-
galactosidase activity assay for all lysates was carried out in a 96 well plate format as 
described previously 27. Total protein concentrations of each sample were measured using 
the Bradford method to ensure equal amounts of total protein were used in the activity 
assays.
To measure mRNA levels, total cellular RNA was purified with a Qiagen RNeasy kit and 
treated with DNase I. Equal amounts of total RNA (300–500 ng) from each sample were 
used to make first strand cDNA by random priming (High capacity cDNA reverse 
transcription kit form Applied Biosystem), and the lacZ mRNA were measured with q-PCR 
using SYBR green kit of Applied Biosystem. Immunoblotting with a monoclonal β-
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galactosidase antibody (Santa Cruz cat #: sc-56394) was used to measure β-galactosidase 
protein levels.
Gene silencing in mitochondria
A DNA fragment encoding the mitochondrial targeting signal from OTC leader peptide 
followed by the Flag tag was synthesized and cloned into the expression vector pT7HTb at 
the 5′ end of ASRE. Additional mutations were introduced in the PUF domain of mitoASRE 
to make it recognize UUAUGUG target. The resulting mitoASRE(ND5) were cloned into 
pcDNA3 vector, and the transfected into Hela or 293T cells. The total RNAs and proteins 
were collected 24 hours past transfection for real-time RT-PCR, immunofluorescence 
staining and western blots.
To generated stable cell lines expressing mitochondrial ASRE, we subcloned 
mitoASRE(ND5) and controls into pcDNA5/FRT/TO vector and co-transfected these 
constructs with pOG44 plasmid into the Flp-In T-REx 293 cells (Invitrogen). Stably 
integrated cells were selected and induced as described in supplemental methods.
Mitochondrial translation assay
In vivo mitochondrial translation was conducted as previously described 28,29. Briefly, cells 
harboring mitoASRE(ND5) or mutated mitoASRE(ND5) expression vectors were induced 
with tetracycline for 24 hours as described earlier and washed twice with DMEM media 
lacking cysteine and methionine but supplemented with 10% dialyzed FBS (purchased from 
Invitrogen). The cells were further cultured in this media for 2hr, treated with emetine for 10 
min at a final concentration of 200µg/ml to block cytoplasmic translation, and then 
incubated with the L-[S35] methionine (150µCi/ml, Perkin Elmer) for 1hr. The total proteins 
of each sample were separated with 15% SDS-PAGE gels, and the dried gels were exposed 
to storage phosphor screen for 7 days at −80°C and imaged on a Typhoon Trio+ Scanner 
(GE, Health Care).
Activity assay for mitochondrial complex I
The activity of mitochondrial complex I was measured using a spectrophotometric assay 30. 
Briefly, the cells stably transfected with mitoASRE(ND5) or catalytically inactive 
mitoASRE(ND5) mutant were induced by 10 µg/ml tetracycline, and the mitochondria were 
purified by two centrifugation steps 30. The protein contents of mitochondria preparation 
were quantified with Bradford method, and the mitochondria of 1µg protein equivalent was 
incubated in 25mM KPO4 buffer (pH 7.8) containing 3.5mg/ml BSA, 60µM Dichlorophenol 
Indophenol (DCIP), 70µM decylubiquinone, 1.0 µM antimycine-A and 0.2 mM NADH at 
37°C 30. Reduction of DCIP was followed at OD600 in the interval for 4 min. Difference in 
OD600 was measured in triplicates and normalized against total mitochondrial protein. For 
each sample, we carried out three independent inductions and mitochondria preparations, the 
activity assays were performed in triplicates, and the mean activities relative to the 
uninduced samples were plotted (Fig. 4f). Paired t-test was performed using graph pad prism 
software.
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Figure 1. Design and biochemical characterization of ASREs
(a) Structures of the PUF domain of human pumilio1 (PDB ID: 1M8W) bound by NRE-19 
RNA target (left) and the PIN domain of Smg6 (right). (PDB ID: 2HWW). Three Asp 
residues (indicated in green) near PIN active site were marked. (b) ASRE with PUF-PIN 
configuration was incubated with a cognate RNA substrate for 30 min, and the products 
were resolved in urea-PAGE gel. Inverted ASRE (PIN-PUF) was also tested with same 
reaction condition (lane 5 and 6). (c) Time course of RNA digestion by ASRE(6-2/7-2). 
Digestion was followed in the standard reaction buffer containing 3 mM Mn2+. (d) RNA 
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substrates containing either an NRE site (UGUAUAUA) or 7u6g site (UugAUAUA) were 
incubated with ASRE(Wt) or ASRE(6-2/7-2). The cognate target-ASRE pairs were 
indicated with same color. Lanes 1 and 4 are controls without enzyme. (e) The RNA 
cleavage activities of ASREs are dependent on different divalent metal ions. In all lanes the 
concentrations of metal ions were 3 mM. (f) ASRE cleavage site was mapped by 5′ and 3′ 
RACE using gel-purified RNA products. The positions of two cleavage sites are indicated 
with arrows and the relative frequencies are plotted. The 8-nt binding sequence of PUF is 
shown in bold. (g) The “curve back” model of ASRE best explains the cleavage positions 
mapped in panel f.
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Figure 2. Effects of linker length and structure on ASRE activity
(a) The linker length affects the ASRE activity. In lanes 1 to 4, all reactions were stopped 
after 30 min incubation. At longer reaction time (60 min), non-specific digestion products 
(indicated by asterisks in lane 5) were observed with ASRE containing a dodecapeptide 
linker. (b) The ASRE(6-2/7-2) containing different linker sequences were incubated with its 
cognate substrate and the cleavage of the RNA was detected with urea-PAGE gel. The 
different linkers were chosen from the protein inter-domain linker database. Both the 
sequence and the PDB code were shown. The secondary structures of the linkers are: 
1al04_1: HHHHTTCCCCCCCHHHH; 1sesA_1: HHHHHHHHHHH; 1qaxA_3: 
HHHHTTTHHH; 1pfkA_2: CGGGGGCSCC. The notation of secondary structure follows 
the standard DSSP code (H, α helix; T, hydrogen bonded turn; C, coil; G, 310 helix; S, 
bend). The structures of inter-domain linkers were determined in the natural context of 
respective proteins. Two amino acids (VD, contributed by the SalI site) were preceded in 
each peptide.
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Figure 3. Using ASRE to silence gene expression in E. coli
(a) The activity of β-galactosidase in E. coli strains transformed with ASRE(LacZ) plasmid 
and control plasmids. For each strain, the β-galactosidase activity from multiple independent 
clones (N=2 or 5) in triplicate experiments was measured. The relative β-galactosidase 
activity was normalized to clones transformed with the empty vector and induced with the 
same condition. The uninduced clones containing empty vector was used as the baseline 
activity. Error bars represent the standard error across all clones. (b) The levels of lacZ 
mRNA were measured by qRT-PCR. The samples were in the same order as panel a. LacZ 
levels were normalized to ftsZ mRNA and the relative RNA abundances compared to 
uninduced controls are plotted. Error bars represent the standard error across all clones. (c) 
The effect of ASREs on other mRNAs containing similar recognition sites. The E. coli 
strains transformed with ASRE(LacZ) or empty vector were induced with IPTG, and the 
RNA levels were measured with qRT-PCR. The relative RNA abundances compared to 
vector controls are plotted. Two independent clones were selected in each strain, and the 
inductions were carried out in triplicates. Error bars represent the standard derivations.
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Figure 4. Using ASRE to silence a mitochondrial gene
(a) A diagram of mitochondrial genome. The circular DNA genome of human 
mitochondrion contains genes coding for 13 proteins (color coded for different oxidative 
phosphorylation complexes), two rRNA (16S and 12S) and 22 tRNAs. A unique sequence 
(TTTATGTG) in mtND5 coding region was chose as ASRE target. (b) Diagram of 
mitoASREs containing an N-terminal mitochondrial targeting peptide that after translocation 
will be cleaved (shown by an arrow ). (c) Immunofluorescence of 293 cells expressing 
mitoASREs and a control ASRE. The mitochondria were stained with MitoTracker. (d) The 
changes of mtND5 RNA level 24 hours after the tetracycline induction. Two independent 
inductions were carried out, and the real time RT-PCR experiments were conducted in 
triplicates with GAPDH as internal controls. The average of the relative mtND5 RNA levels 
compared to uninduced samples were plotted, with error bars indicating standard 
derivations. (e) Changes of mtND5 protein after induction. The levels of both mitochondrial 
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encoded proteins (COX1 and cytB) and the nuclear encoded protein (tubulin) were 
measured as controls. (f) Changes of the complex I activity upon induction as measured with 
a spectrophotometric assay 25. For each cell line, the activities relative to uninduced sample 
were plotted. Three independent inductions and mitochondrial preparations were conducted, 
and each sample was measured in triplicates. The mean and standard errors of all samples 
were plotted (* p=0.0014, paired students T-test).
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